The present invention is directed to a composition which is used to enhance the elasticity and/or appearance of tissue. Specifically, the present invention is directed to a composition formulated from peptides or peptide-like compounds having low molecular weights and which substantially correspond
The present invention is directed to a composition which is used to enhance the elasticity and/or appearance of tissue. Specifically, the present invention is directed to a composition formulated from peptides or peptide-like compounds having low molecular weights and which substantially correspond to sequences found in elastin. The present composition specifically includes chemical modification of the peptides described herein, specifically carboxy and amino modification including the addition of amino acids to either end of the peptide fragments.
대표청구항▼
1. A pharmacetical or cosmetic composition comprising a peptide of SEQ ID NO: 48 (Glycine-Alanine-Valine-Valine-Proline-Glutamine).2. The composition of claim 1, wherein said peptide is at a therapeutically effective concentration in a range of about 0.0002% to about 90%.3. The composition of claim
1. A pharmacetical or cosmetic composition comprising a peptide of SEQ ID NO: 48 (Glycine-Alanine-Valine-Valine-Proline-Glutamine).2. The composition of claim 1, wherein said peptide is at a therapeutically effective concentration in a range of about 0.0002% to about 90%.3. The composition of claim 1, wherein said composition is a cosmetic preparation.4. The composition of claim 3, wherein said cosmetic preparation is formulated as a topical preparation to be applied to a patient's skin.5. The composition of claim 4, wherein said topical preparation is selected from the group consisting of an emulsion, lotion, spray, aerosol, powder, ointment, cream and foam.6. The composition of claim 1, wherein said composition is useful in improving tissue turgor.7. The composition of claim 1, wherein said composition further includes a pharmaceutical delivery system.8. The composition of claim 7, wherein said pharmaceutical delivery system is selected from the group consisting of a topical delivery system and a subcutaneous delivery system.9. The composition of claim 8, wherein said topical delivery system is selected from the group consisting of a cosmetic preparation, powder, emulsion, lotion, spray, ointment, aerosol, cream and foam.10. A peptide selected from the group consisting of SEQ ID 42 (Valine-Proline-Glutamine-Amide), SEQ ID 43 (Acetyl-Valine-Valine-Proline-Glutamine), SEQ ID 44 (Acetyl-Glycine-Alanine-Valine-Valine-Proline-Glutamine-Amide), SEQ ID 45 (Alanine-Valine-Valine-Proline-Glutamine), SEQ ID 46 (Glycine-Alanine-Valine-Valine-Proline-Glutamine), SEQ ID 47 (Alanine-Valine-Valine-Proline-Glutamine-Amide), SEQ ID 48 (Glycine-Alanine-Valine-Valine-Proline-Glutamine), SEQ ID 49 (Cysteine-Valine-Valine-Proline-Glutamine-Cysteine), SEQ ID 50 (Cysteine-Alanine-Valine-Valine-Proline-Glutamine-Cysteine), SEQ ID 51 (Cysteine-Glycine-Alanine-Valine-Valine-Proline-Glutamine-Cysteine), SEQ ID 52 (Cysteine-Valine-Valine-Proline-Glutamine-Cysteine), SEQ ID 53 (Cysteine-Alanine-Valine-Valine-Proline-Glutamine-Cysteine), and SEQ ID 54 (Cysteine-Glycine-Alanine-Valine-Valine-Proline-Glutamine-Cysteine).11. A pharmaceutical composition comprising a peptide of SEQ ID 48 (Glycine-Alanine-Valine-Valine-Proline-Glutamine).12. A cosmetic preparation comprising a peptide of SEQ ID 48 (Glycine-Alanine-Valine-Valine-Proline-Glutamine).13. The peptide as set forth in claim 10, where the peptide is peptide of SEQ ID NO: 45 (Alanine-Valine-Valine-Proline-Glutamine).14. The peptide as set forth in claim 10, where the peptide is peptide of SEQ ID NO: 50 (Cysteine-Alanine-Valine-Valine-Proline-Glutamine-Cysteine).15. The peptide as set forth in claim 10, where the peptide is peptide of SEQ ID NO: 53 (Cysteine-Alanine-Valine-Valine-Proline-Glutamine-Cysteine).
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (36)
Nakamura Yasunori (Yokohama JPX) Takano Toshiaki (Kawasaki JPX), Angiotensin converting enzyme inhibitor and method for preparing same.
Bridgham John (Palo Alto CA) Geiser Timothy G. (La Honda CA) Hunkapiller Michael W. (San Carlos CA) Kent Stephen B. H. (Pasadena CA) Marriott Mark P. (Los Altos CA) Ramstad Paul O. (Oakland CA) Nordm, Automated polypeptide synthesis apparatus.
Bridgham John (Palo Alto CA) Geiser Timothy G. (La Honda CA) Hunkapiller Michael W. (San Carlos CA) Kent Stephen B. H. (Pasadena CA) Marriott Mark P. (Los Altos CA) Ramstad Paul O. (Oakland CA) Nordm, Automated polypeptide synthesis process.
Bouillon Claude (Eaubonne FRX) Darmenton Patrick (Villejuif FRX), Composition for strengthening and revitalizing brittle or damaged nails containing a salt of 2-benzylthio ethylamine.
Rabaud Michel (Talence FRX) Lefebure Clement Francoise (St Medard en Jalles FRX) Bricaud Henri (Cambes FRX) Schmidthaeusler Roland (Illkirch-Graffenstaden FRX), Elastin-based product, a procedure for its preparation and its biological applications; in particular as biomaterials an.
Janzen Ernst (GR Laren NLX) Hoekstra Matthias J. (RP Amstelveen NLX) Dutrieux Richard P. (Amsterdam NLX), Injectable compositions for soft tissue augmentation.
Kligman Albert M. (c/o Department of Dermatology ; University of Pennsylvania Philadelphia PA 19104), Methods for retarding the effects of aging of the skin.
Kligman Albert M. (c/o Dept. of Dermatology ; University of Pennsylvania Philadelphia PA 19104), Methods for treatment of sundamaged human skin with retinoids.
Ferrari Franco A. ; Richardson Charles ; Chambers James ; Causey Stuart ; Pollock Thomas J. ; Cappello Joseph ; Crissman John W., Peptides comprising repetitive units of amino acids and DNA sequences encoding the same.
Bouillon, Claude; Abegg, Jean-Louis; Koulbanis, Constantin; Darmenton, Patrick, Process for reinforcing fragile or brittle nails and a composition containing a cationic polymer for use in said process.
Eckmayer Zdenek (Weinheim DEX) Janzen Ernst (GR Laren NLX) Rttgers Gnter (Stolberg DEX), Process for the manufacture of collagen membranes used for hemostasis, the dressing of wounds and for implants.
Avrameas Alexandre (Vitry-Sur-Seine FRX) Pancino Gianfranco (Paris FRX) Sibille Pierre (La Varenne FRX) Sonigo Pierre (Paris FRX) Strosberg Arthur Donny (Paris FRX), Specific peptide fragment of the feline immunodeficiency virus (FIV), and its use as a diagnostic reagent.
Dumas Marc,FRX ; Bonte Frederic,FRX ; Meybeck Alain,FRX ; Chaudagne Catherine,FRX, Use of vitamin C or derivatives or analogues thereof promoting skin elastin synthesis.
Milech, Nadia Marian Dorothy; Watt, Paul Michael; Holt, Patrick G.; Strickland, Deborah, Compositions and uses thereof for the treatment of acute respiratory distress syndrome (ARDS) and clinical disorders associated with therewith.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.